214 related articles for article (PubMed ID: 33519667)
1. Quantitative Evaluation of
Matsuda H; Ito K; Ishii K; Shimosegawa E; Okazawa H; Mishina M; Mizumura S; Ishii K; Okita K; Shigemoto Y; Kato T; Takenaka A; Kaida H; Hanaoka K; Matsunaga K; Hatazawa J; Ikawa M; Tsujikawa T; Morooka M; Ishibashi K; Kameyama M; Yamao T; Miwa K; Ogawa M; Sato N
Front Neurol; 2020; 11():578753. PubMed ID: 33519667
[No Abstract] [Full Text] [Related]
2. Clinical impact of amyloid PET using
Matsuda H; Okita K; Motoi Y; Mizuno T; Ikeda M; Sanjo N; Murakami K; Kambe T; Takayama T; Yamada K; Suehiro T; Matsunaga K; Yokota T; Tateishi U; Shigemoto Y; Kimura Y; Chiba E; Kawashima T; Tomo Y; Tachimori H; Kimura Y; Sato N
Ann Nucl Med; 2022 Dec; 36(12):1039-1049. PubMed ID: 36194355
[TBL] [Abstract][Full Text] [Related]
3. Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.
Imabayashi E; Tamamura N; Yamaguchi Y; Kamitaka Y; Sakata M; Ishii K
Ann Nucl Med; 2022 Oct; 36(10):865-875. PubMed ID: 35821311
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of semi-quantitative measures of
Müller EG; Stokke C; Stokmo HL; Edwin TH; Knapskog AB; Revheim ME
Quant Imaging Med Surg; 2022 Jan; 12(1):493-509. PubMed ID: 34993096
[TBL] [Abstract][Full Text] [Related]
5. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
[TBL] [Abstract][Full Text] [Related]
6. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
Thurfjell L; Lilja J; Lundqvist R; Buckley C; Smith A; Vandenberghe R; Sherwin P
J Nucl Med; 2014 Oct; 55(10):1623-8. PubMed ID: 25146124
[TBL] [Abstract][Full Text] [Related]
7. Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer's disease, subjects with amnestic mild cognitive impairment and healthy volunteers.
Miki T; Shimada H; Kim JS; Yamamoto Y; Sugino M; Kowa H; Heurling K; Zanette M; Sherwin PF; Senda M
Ann Nucl Med; 2017 Apr; 31(3):260-272. PubMed ID: 28181118
[TBL] [Abstract][Full Text] [Related]
8. Is there a difference in regional read [
Farrar G; Molinuevo JL; Zanette M
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1299-1308. PubMed ID: 30863934
[TBL] [Abstract][Full Text] [Related]
9. Software compatibility analysis for quantitative measures of [
Pemberton HG; Buckley C; Battle M; Bollack A; Patel V; Tomova P; Cooke D; Balhorn W; Hegedorn K; Lilja J; Brand C; Farrar G
EJNMMI Res; 2023 May; 13(1):48. PubMed ID: 37225974
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study.
Okada Y; Kato T; Iwata K; Kimura Y; Nakamura A; Hattori H; Toyama H; Ishii K; Ishii K; Senda M; Ito K; Iwatsubo T;
Ann Nucl Med; 2020 Feb; 34(2):108-118. PubMed ID: 31749127
[TBL] [Abstract][Full Text] [Related]
11. Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [
Hanseeuw BJ; Malotaux V; Dricot L; Quenon L; Sznajer Y; Cerman J; Woodard JL; Buckley C; Farrar G; Ivanoiu A; Lhommel R
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):302-310. PubMed ID: 32601802
[TBL] [Abstract][Full Text] [Related]
12. Effect of different examination conditions on image quality and quantitative value of amyloid positron emission tomography using
Otani T; Otsuka H; Matsushita K; Otomi Y; Kunikane Y; Azane S; Amano M; Harada M; Miyoshi H
Ann Nucl Med; 2021 Sep; 35(9):1004-1014. PubMed ID: 34046870
[TBL] [Abstract][Full Text] [Related]
13. A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [
Bucci M; Savitcheva I; Farrar G; Salvadó G; Collij L; Doré V; Gispert JD; Gunn R; Hanseeuw B; Hansson O; Shekari M; Lhommel R; Molinuevo JL; Rowe C; Sur C; Whittington A; Buckley C; Nordberg A
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2183-2199. PubMed ID: 33844055
[TBL] [Abstract][Full Text] [Related]
14. Centiloid scaling for quantification of brain amyloid with [
Battle MR; Pillay LC; Lowe VJ; Knopman D; Kemp B; Rowe CC; Doré V; Villemagne VL; Buckley CJ
EJNMMI Res; 2018 Dec; 8(1):107. PubMed ID: 30519791
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of
Sur C; Adamczuk K; Scott D; Kost J; Sampat M; Buckley C; Farrar G; Newton B; Suhy J; Bennacef I; Egan MF
Mol Imaging Biol; 2022 Dec; 24(6):862-873. PubMed ID: 35794343
[TBL] [Abstract][Full Text] [Related]
16. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
Ikonomovic MD; Buckley CJ; Heurling K; Sherwin P; Jones PA; Zanette M; Mathis CA; Klunk WE; Chakrabarty A; Ironside J; Ismail A; Smith C; Thal DR; Beach TG; Farrar G; Smith AP
Acta Neuropathol Commun; 2016 Dec; 4(1):130. PubMed ID: 27955679
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic effectiveness of quantitative [¹⁸F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus.
Leinonen V; Rinne JO; Wong DF; Wolk DA; Trojanowski JQ; Sherwin PF; Smith A; Heurling K; Su M; Grachev ID
Acta Neuropathol Commun; 2014 Apr; 2():46. PubMed ID: 24755237
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes.
Schreiber S; Landau SM; Fero A; Schreiber F; Jagust WJ;
JAMA Neurol; 2015 Oct; 72(10):1183-90. PubMed ID: 26280102
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic impact of [
Zwan MD; Bouwman FH; Konijnenberg E; van der Flier WM; Lammertsma AA; Verhey FR; Aalten P; van Berckel BN; Scheltens P
Alzheimers Res Ther; 2017 Jan; 9(1):2. PubMed ID: 28093088
[TBL] [Abstract][Full Text] [Related]
20. Assessing Amyloid Pathology in Cognitively Normal Subjects Using
Collij LE; Konijnenberg E; Reimand J; Kate MT; Braber AD; Lopes Alves I; Zwan M; Yaqub M; van Assema DME; Wink AM; Lammertsma AA; Scheltens P; Visser PJ; Barkhof F; van Berckel BNM
J Nucl Med; 2019 Apr; 60(4):541-547. PubMed ID: 30315145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
